Impact of Anesthetics on Immune Functions in a Rat Model of Vagus Nerve Stimulation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Picq, Chloé A ^a,b   Clarençon, Didier ^a,b   Sinniger, Valérie E ^b   Bonaz, Bruno L ^b,c   Mayol, Jean François S ^a  

^a INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^b CHU La Tronche and University   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; ISOFLURANE; PENTOBARBITAL; TUMOR NECROSIS FACTOR ALPHA; ACETYLCHOLINE; ANESTHETIC AGENT; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE SUBPOPULATION; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VAGUS NERVE STIMULATION; ANIMAL; DRUG EFFECTS; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; VAGUS NERVE;

ANIMALIA; RATTUS;

ACETYLCHOLINE; ANESTHETICS; ANIMALS; CYTOKINES; MALE; RATS; RATS, SPRAGUE-DAWLEY; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84879482114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067086     Document Type: Article

References (32)

1. Tracey KJ, (2009) Reflex control of immunity. Nat Rev Immunol 9: 418-428.
2. Bonaz B, (2007) The cholinergic anti-inflammatory pathway and the gastrointestinal tract. Gastroenterology 133: 1370-1373.
3. Pavlov VA, Tracey KJ, (2005) The cholinergic anti-inflammatory pathway. Brain Behav Immun 19: 493-499.
4. Meregnani J, Clarencon D, Vivier M, Peinnequin A, Mouret C, et al. (2011) Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 160: 82-89.
5. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
6. Karimi K, Bienenstock J, Wang L, Forsythe P, (2010) The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun 24: 316-323.
7. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, et al. (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203: 1623-1628.
8. Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ, (2012) Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev 248: 188-204.
9. Kawaguchi M, Shimizu K, Furuya H, Sakamoto T, Ohnishi H, et al. (1996) Effect of isoflurane on motor-evoked potentials induced by direct electrical stimulation of the exposed motor cortex with single, double, and triple stimuli in rats. Anesthesiology 85: 1176-1183.
10. Yamamoto M, Hatano Y, Ogawa K, Iranami H, Tajima T, (1998) Halothane and isoflurane attenuate the relaxant response to nonadrenergic and noncholinergic nerve stimulation of isolated canine cerebral arteries. Anesth Analg 86: 552-556.
11. Saad MM, Eom W, Hu G, Kim SJ, Crystal GJ, (2010) Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils. Can J Anaesth 57: 50-57.
12. Chung IS, Kim JA, Choi HS, Lee JJ, Yang M, et al. (2013) Reactive Oxygen Species by Isoflurane Mediates Inhibition of Nuclear Factor kappaB Activation in Lipopolysaccharide-Induced Acute Inflammation of the Lung. Anesth Analg 116: 327-335.
13. Boost KA, Leipold T, Scheiermann P, Hoegl S, Sadik CD, et al. (2009) Sevoflurane and isoflurane decrease TNF-alpha-induced gene expression in human monocytic THP-1 cells: potential role of intracellular IkappaBalpha regulation. Int J Mol Med 23: 665-671.
14. Flondor M, Hofstetter C, Boost KA, Betz C, Homann M, et al. (2008) Isoflurane inhalation after induction of endotoxemia in rats attenuates the systemic cytokine response. Eur Surg Res 40: 1-6.
15. Hofstetter C, Boost KA, Hoegl S, Flondor M, Scheller B, et al. (2007) Norepinephrine and vasopressin counteract anti-inflammatory effects of isoflurane in endotoxemic rats. Int J Mol Med 20: 597-604.
16. Mitsuhata H, Shimizu R, Yokoyama MM, (1995) Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 17: 529-534.
17. Tschaikowsky K, Ritter J, Schroppel K, Kuhn M, (2000) Volatile anesthetics differentially affect immunostimulated expression of inducible nitric oxide synthase: role of intracellular calcium. Anesthesiology 92: 1093-1102.
18. de Rossi LW, Brueckmann M, Rex S, Barderschneider M, Buhre W, et al. (2004) Xenon and isoflurane differentially modulate lipopolysaccharide-induced activation of the nuclear transcription factor KB and production of tumor necrosis factor-alpha and interleukin-6 in monocytes. Anesth Analg 98: 1007-1012.
19. Kim M, Park SW, D'Agati VD, Lee HT, (2012) Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-beta1 generation. Ann Surg 255: 492-503.
20. Mu J, Xie K, Hou L, Peng D, Shang L, et al. (2010) Subanesthetic dose of isoflurane protects against zymosan-induced generalized inflammation and its associated acute lung injury in mice. Shock 34: 183-189.
21. Plachinta RV, Hayes JK, Cerilli LA, Rich GF, (2003) Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. Anesthesiology 98: 89-95.
22. Hofstetter C, Flondor M, Boost KA, Koehler P, Bosmann M, et al. (2005) A brief exposure to isoflurane (50 s) significantly impacts on plasma cytokine levels in endotoxemic rats. Int Immunopharmacol 5: 1519-1522.
23. Reyt S, Picq C, Sinniger V, Clarencon D, Bonaz B, et al. (2010) Dynamic Causal Modelling and physiological confounds: a functional MRI study of vagus nerve stimulation. Neuroimage 52: 1456-1464.
24. Zaaimi B, Grebe R, Wallois F, (2008) Animal model of the short-term cardiorespiratory effects of intermittent vagus nerve stimulation. Auton Neurosci 143: 20-26.
25. Hotta H, Lazar J, Orman R, Koizumi K, Shiba K, et al. (2009) Vagus nerve stimulation-induced bradyarrhythmias in rats. Auton Neurosci 151: 98-105.
26. Roederer M, (2001) Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45: 194-205.
27. Bedirli N, Demirtas CY, Akkaya T, Salman B, Alper M, et al. (2012) Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation. J Surg Res 178: e17-23.
28. Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, et al. (2008) Anesthetics impact the resolution of inflammation. PLoS One 3: e1879.
29. Park WR, Nakahira M, Sugimoto N, Bian Y, Yashiro-Ohtani Y, et al. (2004) A mechanism underlying STAT4-mediated up-regulation of IFN-gamma induction inTCR-triggered T cells. Int Immunol 16: 295-302.
30. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Buschenfelde KH, et al. (1998) IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol 160: 3642-3647.
31. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW, (2004) Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 101: 1313-1324.
32. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ, (2003) The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9: 125-134.